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Level of Exercise Influences the Severity of Fatigue, Energy Levels, and Sleep 
Disturbance in Oncology Outpatients Receiving Chemotherapy, Sally Moy, Abstract 
Background – Fatigue and sleep disturbance are common co-occurring symptoms in patients 
receiving chemotherapy (CTX). While the results from the meta-analyses support the use of 
exercise to decrease the severity of these symptoms, information is needed on patients’ “real 
world experiences” with the use of exercise during CTX. 
Objective – Determine the distribution of patients who did and did not exercise on a regular 
basis and evaluate for differences in demographic and clinical characteristics, as well as the 
severity of fatigue, decrements in energy, and sleep disturbance among the exercise groups. 
Methods – Patients (n=1033) completed self-report questionnaires prior to their second or third 
cycle of CTX. Patients were categorized into 3 exercise (Ex) groups (i.e., NoEx, <150 
minutes/week (LessEx), >150 minutes/week (RecEx). Differences among the groups were 
evaluated using parametric and nonparametric tests. 
Results – Only 19.1% of the patients were in the RecEx group. Patients in the NoEx group 
(37.2%) were had fewer years of education, were more likely to be non-white and unemployed, 
had a higher BMI and a worse comorbidity profile. Patients in the NoEx group had higher levels 
of morning fatigue, lower levels of morning and evening energy, and higher levels of sleep 
disturbance. 
Conclusions – Findings from this “real world” study suggest that lack of physical activity is 
associated with higher levels of fatigue and sleep disturbance. 
Implications for Practice – Given that the most frequently used intervention in this study was 
walking, clinicians can recommend this inexpensive intervention to patients to manage fatigue 
and sleep disturbance. 
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INTRODUCTION 
 Over 50% of oncology patients will receive surgery and chemotherapy (CTX) to treat 
their cancer.[1] Fatigue is one of the most common and distressing symptoms that occurs in 
70% to 100% of patients receiving CTX.[2] Cancer-related fatigue is defined as a “distressing, 
persistent, subjective sense of physical, emotional, or cognitive tiredness or exhaustion related 
to cancer or cancer treatment that is not proportional to recent activity and interferes with usual 
functioning”.[3] As outlined in several reviews,[4-6] the underlying mechanisms for fatigue are 
multifactorial and include: immune activation and inflammation, activation of the hypothalamic-
pituitary-adrenal axis, metabolic and/or endocrine dysfunction, disruption in circadian rhythms, 
and abnormalities in neuromuscular function. 
An equally common and problematic symptom in patients receiving CTX is sleep 
disturbance. While not routinely assessed, occurrence rates for sleep disturbance range from 
30% to 60%.[7, 8] In one study of patients receiving CTX,[9] prevalence rates for sleep 
disturbance were three times higher than in the general population. Similar to fatigue, the 
underlying mechanisms for sleep disturbance in oncology patients are multifactorial and not 
completely understood. As noted in one review,[10] the cancer itself as well as the receipt of 
CTX induces systemic inflammation as well as disruptions in metabolic and endocrine functions 
that can have a negative effect on sleep neurocircuitry. 
Emerging evidence suggests that fatigue and sleep disturbance co-occur in oncology 
patients [11, 12] because they share common underlying mechanisms.[13] Across several 
studies, our research team reported that higher levels of fatigue prior to the initiation of radiation 
therapy,[14] prior to surgery for breast cancer,[15] and prior to CTX [16] were associated with 
higher levels of sleep disturbance over time. Similar associations were found when fatigue was 
the dependent variable in the longitudinal analyses (i.e., higher levels of sleep disturbance 
predicted higher levels of fatigue over time [17-21]). Despite the high occurrence rates, relative 
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inter-relatedness, and detrimental effects of both symptoms on oncology patients’ functional 
status and quality of life (QOL), effective treatments for both symptoms are lacking. 
A growing body of evidence suggests that exercise is a cost effective intervention to 
decrease the incidence of cancer and inhibit tumor growth.[22-25] While the mechanisms that 
underlie the efficacy of exercise are not well understood, current data suggest that exercise may 
effect tumor growth through the mobilization and activation of cytotoxic immune cells and 
regulation of acute and chronic systemic inflammatory responses.[23] Given that an alteration in 
inflammatory responses associated with the administration of CTX is one of the hypothesized 
mechanisms for both fatigue and sleep disturbance, a number of randomized clinical trials have 
evaluated the efficacy of exercise for these symptoms. In terms of fatigue, across several 
systematic reviews and meta-analyses of patients undergoing active treatment as well as 
cancer survivors,[26-34] the findings suggest that multimodal exercise interventions that include 
aerobic, resistance, and stretching exercises are effective in decreasing fatigue. While less well 
studied and often evaluated as a secondary outcome,[35-38] findings from four systematic 
reviews suggest that regular exercise results in decreases in sleep disturbance. 
While the results from the meta-analyses cited above support the use of exercise to 
decrease fatigue and sleep disturbance in oncology patients undergoing CTX, information is 
needed on patients’ “real world experiences” with the use of exercise and its association with 
symptom severity. Five studies were identified that used self-report measures to evaluate levels 
of exercise in oncology patients undergoing cancer treatment.[39-43] Across these five studies, 
between 7% [40] and 55.9% [42] reported that they did not engage in routine physical activity. 
While in one study, fatigue was found to be a significant barrier to regular exercise,[40] only one 
study evaluated the relationships between exercise and the severity of fatigue and sleep 
disturbance in women (n=119) with breast, ovarian, or colorectal cancer prior to their second 
dose of CTX. [42] While no differences in sleep disturbance scores were found between the 
exercisers and non-exercisers, lower fatigue scores were reported by the exercise group at 
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enrollment. Given the paucity of “real world data” on the relationships between exercise and 
fatigue and sleep disturbance, the purposes of this study in a sample of patients undergoing 
CTX (n = 1033) were to: determine the distribution of patients who did and did not exercise on a 
regular basis using the recommendation for physical activity from the Office of Disease 
Prevention and Health Promotion’s Healthy People 2020 report (i.e., >150 minutes of exercise 
per week) [44]; evaluate for differences in demographic and clinical characteristics among the 
exercise groups; and evaluate for differences in the severity of fatigue, decrements in energy, 
and sleep disturbance among the exercise groups. 
METHODS 
Patients and settings 
 This analysis is part of a longitudinal study that evaluated the symptom experience of 
oncology outpatients receiving CTX. Eligible patients were ≥18 years of age; had a diagnosis of 
breast, gastrointestinal, gynecological, or lung cancer; had received CTX within the preceding 
four weeks; were scheduled to receive at least two additional cycles of CTX; were able to read, 
write, and understand English; and gave written informed consent. Patients were recruited from 
two Comprehensive Cancer Centers, one Veteran’s Affairs hospital, and four community-based 
oncology programs. A total of 2234 patients were approached and 1343 consented to 
participate (60.1% response rate). The major reason for refusal was being overwhelmed with 
their cancer treatment. 
Evaluation of regular exercise 
Patients (n=1033) completed a 6-item exercise questionnaire that asked them whether 
or not they exercised on a regular basis; what types of physical activity they engaged in at the 
present time (e.g., walk, swim); how many days per week they exercised; how many times per 
day they exercised; as well as the duration and intensity of each session. Based on responses 
to this questionnaire, three exercise groups were created: patients who did not exercise on a 
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regular basis (NoEx); patients who exercised <150 minutes per week (LessEx); and patients 
who exercised for the recommended >150 minutes per week (RecEx). [44]  
Instruments 
 A demographic questionnaire obtained information on age, gender, ethnicity, marital 
status, living arrangements, education, employment status, and income. In addition, patients 
completed the Karnofsky Performance Status (KPS) scale)[45] and the Self-Administered 
Comorbidity Questionnaire (SCQ.[46]  
The 18-item Lee Fatigue Scale (LFS) was designed to assess physical fatigue and 
energy.[47] Each item was rated on a 0 to 10 numeric rating scale (NRS). Total fatigue and 
energy scores were calculated as the mean of the 13 fatigue items and the 5 energy items, 
respectively. Higher scores indicate greater fatigue severity and higher levels of energy. Using 
separate LFS questionnaires, patients were asked to rate each item based on how they felt 
within 30 minutes of awakening (i.e., morning fatigue, morning energy) and prior to going to bed 
(i.e., evening fatigue, evening energy). The LFS has established cutoff scores for clinically 
meaningful levels of fatigue (i.e., ≥3.2 for morning fatigue, ≥5.6 for evening fatigue) [48] and 
energy (i.e., <6.2 for morning energy, <3.5 for evening energy).[48] The LFS has well 
established validity and reliability.[47, 49] In the current study, the Cronbach’s alphas were 0.96 
for morning and 0.93 for evening fatigue and 0.95 for morning and 0.93 for evening energy. 
The 21-item General Sleep Disturbance Scale (GSDS) was designed to assess the 
quality of sleep. Each item was rated on a 0 (never) to 7 (everyday) NRS. The GSDS total score 
is the sum of the seven subscale scores that can range from 0 (no disturbance) to 147 (extreme 
sleep disturbance). Each mean subscale score can range from 0 to 7. Higher total and subscale 
scores indicate higher levels of sleep disturbance. Subscales scores of >3 and a GSDS total 
score of >43 indicate a significant level of sleep disturbance.[48] The GSDS has well 
established validity and reliability.[49-51] In the current study, the Cronbach’s alpha for the 
GSDS total score was 0.83. 
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Study procedures 
 The study was approved by the Committee on Human Research at the University of 
California, San Francisco and by the Institutional Review Board at each of the study sites. 
Eligible patients were approached by a research staff member in the infusion unit during their 
first or second cycle of CTX to discuss participation in the study. Written informed consent was 
obtained from all patients. Depending on the length of their CTX cycles, patients completed 
questionnaires in their homes, a total of six times over two cycles of CTX. For this analysis, 
symptom data from the enrollment assessment, that asked patients to report on their symptom 
experience for the week prior to the administration of their next cycle of CTX, were analyzed 
(i.e., recovery from previous CTX cycle). Medical records were reviewed for disease and 
treatment information. 
Data analysis 
Data were analyzed using SPSS version 25 (IBM, Armonk, NY). Descriptive statistics 
and frequency distributions were calculated for demographic, clinical, and symptom 
characteristics. The three exercise groups were created using the patients’ responses to the 
exercise questionnaire. Patients who responded no to the question about whether or not they 
exercised on a regular basis were assigned to the NoEX group. The remaining two groups were 
assigned based on a calculation of the number of times they exercised per week, the number of 
times per day that they exercised, and the duration of the exercise sessions. Differences among 
the three exercise groups in demographic and clinical characteristics, as well symptom severity 
scores, were evaluated using analysis of variance, Chi square analyses, or Kruskal-Wallis tests.  
A p-value of <.05 was considered statistically significant. Post hoc contrasts were done using a 
Bonferroni corrected p-value of <.017 (.05/3 pairwise comparisons). 
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RESULTS 
Classification of the exercise groups 
 Of the 1033 patients who completed the exercise questionnaire, 37.2% were classified in 
the NoEx group, 43.7% in the LessEx group, and 19.1% in the RecEx group. As shown in 
Figures 1A to ID, compared to the RecEx group, patients in the LessEx group, exercised for 
fewer minutes per session as well as for fewer total minutes per week and participated in less 
intense exercise and for fewer days per week (all, p<.001) Differences between the two groups 
in the types of exercise are illustrated in Figure 2. 
 
 
 
Figure 1: (A) Comparison of minutes per exercise session in LessEx vs. RecEx. (B) 
Comparison of frequency of exercise sessions in LessEx vs. RecEx. (C) Comparison of 
exercise intensity in LessEx vs. RecEx. (D) Comparison of minutes of exercise per week in 
LessEx vs. RecEx.  
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Figure 2: Comparison of types of exercise undertaken by LessEx vs. RecEx patients. 
 
 
Differences in demographic and clinical characteristics 
 In terms of demographic characteristics, statistically significant differences were found 
among the three exercise groups in level of education (NoEx < Less Ex < RecEx). In addition, 
compared to the RecEx group, patients in the NoEx group were more likely to be Nonwhite and 
less likely to be employed. Compared to the RecEx group, patients in the other two groups 
reported a lower annual household income. 
 In terms of clinical characteristics, statistically significant differences were found among 
the three exercise groups in body mass index (BMI; NoEx > LessEx > RecEx) and KPS score 
(NoEx < LessEx < RecEx). Compared to the other two exercise groups, patients in the NoEx 
group had a higher number of comorbidities, a higher SCQ score, were more likely to have high 
blood pressure, and were less likely to have breast cancer than the other cancer diagnoses. 
Compared to the RecEx group, patients in the other two exercise groups were more likely to 
report diabetes and back pain. 
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Differences in fatigue and energy 
While no significant differences were found in evening fatigue among the three exercise 
groups, compared to the other two groups, patients in the NoEx group had significantly higher 
levels of morning fatigue. In terms of morning energy, statistically significant differences were 
found among the three groups (NoEx < Less Ex < RecEx). In terms of evening energy, 
compared to the RecEx group, patients in the NoEx group reported significantly lower energy 
levels (Table 2).  
Differences in sleep disturbance 
 No differences were found among the three exercise groups in the GSDS subscale 
scores for: quantity of sleep, sleep onset latency, mid-sleep awakenings, early awakenings, and 
medication for sleep. Compared to the RecEx group, patients in the NoEx group reported 
significantly higher scores for quality of sleep (which indicates poorer sleep quality) and overall 
level of sleep disturbance. 
DISCUSSION 
This large “real world” study of oncology patients receiving CTX is the first to evaluate for 
differences in the severity of fatigue, decrements in energy, and sleep disturbance based on 
self-reported levels of exercise. Only 19% of patients in our study were categorized as meeting 
the Healthy People 2020 guideline recommendation to exercise for >150 min/week. This 
percentage is higher than the 7% found in a Danish study of patients undergoing CTX [40] but 
lower than the 55.9% reported by women with breast, colorectal, and ovarian cancer who were 
beginning their first cycle of CTX.[42] A comparison of findings across studies is challenging due 
to heterogeneity in cancer diagnoses and treatment regimens, the methods used to assess 
physical activity, as well as the timing of the measures in relationship to cancer treatments. In 
terms of the general population of the United States, less than 5% of adults participate in 30 
minutes of physical activity each day and only one in three meet the recommended amount of 
physical activity each week.[52]  
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Ethnicity was one of the demographic characteristics associated with reporting lower 
levels of exercise. Consistent with studies of the general population,[53, 54] Nonwhites were 
more likely to be in the NoEx or LessEx groups. These differences may occur because of the 
higher likelihood that members of ethnic minority groups may have decreased access to safe 
public parks and recreational facilities in their neighborhoods. In addition, these individuals are 
more likely to have physically demanding jobs with work hours that reduce their opportunities to 
engage in more physically active leisure activities.[53, 55-58]  
 Years of education was another demographic characteristic that differentiated among 
the three exercise groups, with patients in the NoEx group having the fewest years of education. 
Again, this finding is consistent with trends in the general population,[59, 60] as well as with a 
number of intervention studies that found that oncology patients with more education had higher 
rates of adherence with prescribed exercise regimens.[61-63] The complex relationship 
between education and health, often referred to as an education gradient, is partially explained 
by the idea that individuals with more years of education have higher incomes that provide 
increased access to resources (e.g., gym memberships); afford more time for health-related 
activities; and provide access to social networks that can amplify health behaviors like 
exercise.[60, 64, 65] This hypothesis is consistent with our findings that a significantly higher 
percentage of patients in the NoEx were less likely to be employed and reported a lower annual 
household income. 
 Consistent with previous studies,[66, 67] compared to the RecEx group, patients in the 
NoEx group had a higher BMI, a worse comorbidity profile, a higher number of metastatic sites, 
were more likely to have high blood pressure, diabetes, and back pain, and had a lower 
functional status. While patients in the RecEx group had a BMI in the normal range, patients in 
the other two exercise groups had BMIs in the overweight range.[68] In general, studies have 
found that a higher number of comorbidities is associated with less physical activity.[69, 70] 
Long-term inactivity and lack of exercise may impair normal organ function and lead to an 
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increased risk for chronic diseases like hypertension, diabetes, and back pain.[71] While all of 
these demographic and clinical characteristics associated with being in the LessEx group were 
reported in studies of the general population, clinicians caring for oncology patients should use 
this constellation of characteristics to identify high risk patients and initiate appropriate referrals 
to physical therapists, exercise physiologists, dieticians, and social workers. 
As noted in the introduction, findings from several systematic reviews and meta-
analyses,[26-34] suggest that multimodal exercise interventions are effective in decreasing 
fatigue. This study is the first to evaluate the relationships between levels of exercise and self-
reports of morning and evening fatigue, as well as decrements in morning and evening energy. 
None of the previous intervention studies evaluated the effects of exercise on diurnal variations 
in fatigue severity. In our study, while no differences were found among the exercise groups in 
the severity of evening fatigue, all of these scores were near the clinically meaningful cutoff 
score for evening fatigue. In contrast, compared to the other two exercise groups, only the 
patients in the NoEx group had significantly higher levels of morning fatigue that were above the 
clinically meaningful cutoff score.  
Equally interesting is our findings on the associations between exercise and decrements 
in energy levels. While most of the literature uses the terms energy and fatigue 
interchangeably,[72, 73] a growing body of evidence from our group [74, 75] and others [76-78] 
suggests that energy and fatigue are distinct but related symptoms. In our previous report of 
characteristics associated with inter-individual differences in the trajectories of morning and 
evening energy,[74] lack of regular exercise (i.e., dichotomous outcome) was associated with 
significantly lower levels of morning but not evening energy. However, in the current study, our 
findings suggest that level of exercise influences decrements in both morning and evening 
energy. Compared to the RecEx group, patients in the NoEx group had significantly lower levels 
of evening energy that were below the clinically meaningful cutoff score. While all of the patients 
in this study had morning energy scores that were below the clinically meaningful cutoff, the 
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effects of exercise appear to follow a dose response (NoEx < LessEx < RecEx). Taken together 
with our fatigue findings, future intervention studies should evaluate the effects of exercise on 
diurnal variations in both fatigue and energy. 
While less well studied and often evaluated as a secondary outcome,[35-38] the 
available evidence suggests that regular exercise results in decreases in sleep disturbance. In 
our study, all of the exercise groups had scores for the majority of the GSDS subscales, as well 
as the total score, that were above the clinically meaningful cutoffs. Consistent with the findings 
from one meta-analysis,[38] patients in the RecEx group reported better sleep quality than the 
NoEx group. Given the recent interest in evaluating the linkages between fatigue and sleep 
disturbance in oncology patients in relationship to the efficacy of exercise,[12] one explanation 
for the low levels of morning energy and high levels of morning fatigue in the NoEx group may 
be their high levels of self-reported sleep disturbance. 
Several limitations need to be acknowledged. Given that exercise was only evaluated at 
enrollment, we cannot determine causal associations between demographic and clinical 
characteristics, as well as symptom severity scores, and levels of physical activity. While levels 
of exercise prior to the initiation of CTX were not evaluated, findings from one study suggest 
that patients’ level of physical activity prior to a cancer diagnosis is a strong predictor of activity 
up to 10 years post-diagnosis.[79] Given that self-reported levels of exercise, that are 
susceptible to recall and social desirability biases,[80] were used in this study, future studies 
should use both subjective and objective measures of physical activity. However, it should be 
noted that self-reported physical activity is moderately correlated with data obtained using an 
accelerometer.[81-83] 
 Despite these limitations, this study provides “real world” evidence of risk factors that 
clinicians can use to identify patients who are least likely to meet the Office of Disease 
Prevention and Health Promotion’s recommendations for regular exercise.[44] In addition, given 
that the most frequently used intervention in this sample was walking, clinicians can recommend 
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this inexpensive exercise to patients to increase their energy levels, as well as decrease fatigue 
and sleep disturbance. Future studies need to examine the relationships among the dose and 
types of exercise and these common symptoms in oncology patients, as well as the 
mechanisms that underlie these inter-relationships. 
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Please see “Table 1: Differences in Demographic and Clinical Characteristics Among the 
Exercise Groups” attached. 
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Please see “Table 2: Differences in Fatigue, Energy, and Sleep Disturbance Scores Among the 
Exercise Groups” attached.  
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